CAH · 10-Q · 2026Q3 · Full report

Regulatory Risk

CARDINAL HEALTH INC · 2026-11-05 · Importance 23 · Surprise 24

In November 2023, Cardinal Health received a Department of Justice Civil Investigative Demand concerning potential Anti-Kickback Statute and False Claims Act violations. The inquiry relates to a 2022 transaction in which Cardinal Health purchased a minority ownership interest in a rheumatology managed services organization and a group purchasing organization. Cardinal Health stated that it is cooperating with the investigation.

Key facts

• The Pharma segment was modifying finance and operating information systems related to ongoing supply chain optimization; ineffective implementation or system failures could adversely affect internal control over financial reporting. source
• Cardinal Health received a Department of Justice Civil Investigative Demand in November 2023 concerning potential Anti-Kickback Statute and False Claims Act violations related to its 2022 purchase of a minority ownership interest in a rheumatology managed services organization and a group purchasing organization; it is cooperating with the investigation. source
• Cardinal Health recognized $47 million of income from net recoveries in class action antitrust lawsuits in which it was a class member or plaintiff during the three months ended September 30, 2026. source